artICleS
Tau promotes neurodegeneration through global chromatin relaxation
Bess Frost1, Martin Hemberg2, Jada Lewis3 & Mel B Feany1
The microtubule-associated protein tau is involved in a number of neurodegenerative disorders, including Alzheimer’s disease. Previous studies have linked oxidative stress and subsequent DNA damage to neuronal death in Alzheimer’s disease and related tauopathies. Given that DNA damage can substantially alter chromatin structure, we examined epigenetic changes in tau-induced neurodegeneration. We found widespread loss of heterochromatin in tau transgenic Drosophila and mice and in human Alzheimer’s disease. Notably, genetic rescue of tau-induced heterochromatin loss substantially reduced neurodegeneration in Drosophila. We identified oxidative stress and subsequent DNA damage as a mechanistic link between transgenic tau expression and
heterochromatin relaxation, and found that heterochromatin loss permitted aberrant gene expression in tauopathies. Furthermore, large-scale analyses from the brains of individuals with Alzheimer’s disease revealed a widespread transcriptional increase in genes that were heterochromatically silenced in controls. Our results establish heterochromatin loss as a toxic effector of tau-induced neurodegeneration and identify chromatin structure as a potential therapeutic target in Alzheimer’s disease.Tauopathies, including Alzheimer’s disease, are characterized patho-logically by the deposition of neurofibrillary tangles composed of the microtubule-associated protein tau in the brains of affected individuals1. The discovery of dominant mutations in the tau gene linked to a familial neurodegenerative disorder, frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17), confirms tau as a causal factor in neurodegenerative disease pathogenesis2–4.
The precise mechanism of tau-induced neurotoxicity remains a critical question in tauopathy research, and understanding the molecular and cellular pathways perturbed by tau in disease states
5is essential for the development of effective therapies. Although
multiple lines of evidence implicate oxidative DNA damage and aber-rant neuronal cell cycle activation in the toxic cascade triggered in tauopathies6–8, the mechanisms controlling the interaction between these processes in terminally differentiated neurons are unknown. Based on recovery of chromatin regulators in unbiased forward genetic screens for modifiers of tau neurotoxicity9,10 (M.B.F., unpub-lished data) and given the fact that chromatin remodeling is associated with oxidative DNA damage and cell cycle regulation11,12, we hypoth-esized that oxidative stress–induced DNA damage causes chromatin alterations that promote cell cycle reentry in tauopathy.
An appropriate balance and distribution of active and repressed chromatin is required for proper transcriptional control, maintain-ing nuclear architecture and genomic stability13, and regulating the cell cycle14. In the nucleus, DNA is packaged into specific chromatin domains known as euchromatin and heterochromatin. Euchromatin is generally gene rich and permissive for gene activation, whereas heterochromatin is relatively gene sparse and transcriptionally qui-escent12. A set of highly conserved proteins and post-translational histone modifications maintain these distinct chromatin domains
along chromosomes in both insects and vertebrates. In particular, dimethylated lysine 9 of histone 3 (H3K9me2) and the heterochro-matin protein 1α (HP1α) are enriched in constitutive telomeric and pericentromeric heterochromatin12. Our results establish a role for H3K9me2, HP1α and heterochromatin loss in tau-mediated neuro-degeneration in insect and vertebrate systems.
RESULTStau蛋白病变模型果蝇的大Heterochromatin loss in tau transgenic Drosophila脑
To explore an association between tau neurotoxicity and chromatin alterations, we first determined whether histone methylation patterns or chromatin-associated proteins are altered in the brains of tauopathy model Drosophila. Pan-neuronal transgenic expression of an FTDP-17 mutant form of human tau, tauR406W, in Drosophila causes progressive neurodegeneration and provides a well-characterized in vivo genetic model of tau neurotoxicity7,15,16. We found that the total levels of H3K9me2 and HP1α were decreased in tau transgenic Drosophila heads compared with controls (Fig. 1a,b). Reverse transcription fol-lowed by PCR (RT-PCR) indicated that mRNA levels of Su(var)3-9, 编码组蛋白which encodes the main histone methyltransferase responsible for 甲基转移酶H3K9二甲基化
H3K9 dimethylation, and Su(var)205, which encodes HP1α, were 和HP1α的
mRNA水平与
equal between control and tau transgenic Drosophila heads, indi-对照组无变cating that the loss of H3K9me2 and HP1α in tauopathy was not 化。a result of transcriptional changes in these genes (Supplementary Fig. 1a). To determine whether heterochromatin loss is specific to
tauR406W versus a general feature of tau pathology, we used trans-

转基因苍蝇genic flies carrying human wild-type tau (tauWT)15 or a pseudohy-perphosphorylated form of human tau (tauE14)7. Tau phosphorylation is an important pathogenic event in Alzheimer’s disease and related tauopathies, and the tauE14 transgene causes substantially more
p© 2014 Nature America, Inc. All rights reserved.
in Neurobiology, Boston Children’s Hospital, Boston, Massachusetts, USA. 3Department of Neuroscience and Center for Translational Research in
Neurodegenerative Disease, University of Florida, Gainesville, Florida, USA. Correspondence should be addressed to M.B.F. (mel_feany@hms.harvard.edu).Received 13 November 2013; accepted 24 December 2013; published online 26 January 2014; doi:10.1038/nn.3639
1Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA. 2Department of Ophthalmology and Program
nature neurOSCIenCe
热门文档